News

Four distinguished faculty from UK were recently named Fellows of prestigious national research organizations.

UK Research had much to celebrate in 2019, growth in research awards—up 25% from FY18 to FY19—to the largest grant in UK’s history, the $87 million HEALing Communities Study from NIH that aims to reduce opioid overdose deaths by 40% in three years. 

Earlier this fall, Dr. Eli Capilouto joined elected officials from across Eastern Kentucky for the Shaping Our Appalachian Region (SOAR) Summit in Pikeville. It was a gathering underscored by hope and guided by a compelling vision.

University of Kentucky (UK) faculty received $417.1 million in competitive research awards last fiscal year, a record-breaking increase of $83 million over the previous year.

Nearly a decade ago, it was a small conference about an issue only starting to come out of the shadows of stigma and shame – the growing epidemic of opioid addiction and substance abuse disorder.

The University of Kentucky is a place defined by its people. This Wednesday, April 17, our community will band together during our first “One Day for UK,” a 24-hour day of giving. As part of the campaign, UK Research is raising money for the Healthy Kentucky Research Building Fund.

Scientific breakthroughs throughout history have arisen from a combination of fierce determination and a desire to improve lives. Breakthroughs at the University of Kentucky have been no different. In this blog, learn about two recent research discoveries related to regeneration and rare earth elements.

New rankings have UK in the top 25 of public research institutions, and UK College of Medicine in the top 25 of all public medical schools in 2018.

John Thelin, a University Research Professor in the educational policy studies and evaluation department in the UK College of Education, has published prolifically on the history of higher education and college sports.

Unfortunately, for far too long, the male sex was the prototypical vehicle for experimental and clinical studies testing new drugs, devices and basic physiologic and pathophysiologic disease processes.